Cryptogenic stroke and underlying atrial fibrillation
- PMID: 24963567
- DOI: 10.1056/NEJMoa1313600
Cryptogenic stroke and underlying atrial fibrillation
Abstract
Background: Current guidelines recommend at least 24 hours of electrocardiographic (ECG) monitoring after an ischemic stroke to rule out atrial fibrillation. However, the most effective duration and type of monitoring have not been established, and the cause of ischemic stroke remains uncertain despite a complete diagnostic evaluation in 20 to 40% of cases (cryptogenic stroke). Detection of atrial fibrillation after cryptogenic stroke has therapeutic implications.
Methods: We conducted a randomized, controlled study of 441 patients to assess whether long-term monitoring with an insertable cardiac monitor (ICM) is more effective than conventional follow-up (control) for detecting atrial fibrillation in patients with cryptogenic stroke. Patients 40 years of age or older with no evidence of atrial fibrillation during at least 24 hours of ECG monitoring underwent randomization within 90 days after the index event. The primary end point was the time to first detection of atrial fibrillation (lasting >30 seconds) within 6 months. Among the secondary end points was the time to first detection of atrial fibrillation within 12 months. Data were analyzed according to the intention-to-treat principle.
Results: By 6 months, atrial fibrillation had been detected in 8.9% of patients in the ICM group (19 patients) versus 1.4% of patients in the control group (3 patients) (hazard ratio, 6.4; 95% confidence interval [CI], 1.9 to 21.7; P<0.001). By 12 months, atrial fibrillation had been detected in 12.4% of patients in the ICM group (29 patients) versus 2.0% of patients in the control group (4 patients) (hazard ratio, 7.3; 95% CI, 2.6 to 20.8; P<0.001).
Conclusions: ECG monitoring with an ICM was superior to conventional follow-up for detecting atrial fibrillation after cryptogenic stroke. (Funded by Medtronic; CRYSTAL AF ClinicalTrials.gov number, NCT00924638.).
Comment in
-
Heart-rhythm monitoring for evaluation of cryptogenic stroke.N Engl J Med. 2014 Jun 26;370(26):2532-3. doi: 10.1056/NEJMe1405046. N Engl J Med. 2014. PMID: 24963573 No abstract available.
-
Atrial fibrillation. Cryptogenic stroke--can we abandon this apologetic diagnosis?Nat Rev Cardiol. 2014 Sep;11(9):504-5. doi: 10.1038/nrcardio.2014.111. Epub 2014 Jul 29. Nat Rev Cardiol. 2014. PMID: 25072906
-
Cryptogenic stroke and atrial fibrillation.N Engl J Med. 2014 Sep 25;371(13):1259. doi: 10.1056/NEJMc1409495. N Engl J Med. 2014. PMID: 25251622 No abstract available.
-
Cryptogenic stroke and atrial fibrillation.N Engl J Med. 2014 Sep 25;371(13):1259-60. doi: 10.1056/NEJMc1409495. N Engl J Med. 2014. PMID: 25251623 No abstract available.
-
Cryptogenic stroke and atrial fibrillation.N Engl J Med. 2014 Sep 25;371(13):1261. doi: 10.1056/NEJMc1409495. N Engl J Med. 2014. PMID: 25259387 No abstract available.
Similar articles
-
Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial.Circ Arrhythm Electrophysiol. 2016 Jan;9(1):e003333. doi: 10.1161/CIRCEP.115.003333. Circ Arrhythm Electrophysiol. 2016. PMID: 26763225 Clinical Trial.
-
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.Health Technol Assess. 2020 Jan;24(5):1-184. doi: 10.3310/hta24050. Health Technol Assess. 2020. PMID: 31944175 Free PMC article.
-
Atrial fibrillation in patients with cryptogenic stroke.N Engl J Med. 2014 Jun 26;370(26):2467-77. doi: 10.1056/NEJMoa1311376. N Engl J Med. 2014. PMID: 24963566 Clinical Trial.
-
A Comparison of Atrial Fibrillation Monitoring Strategies After Cryptogenic Stroke (from the Cryptogenic Stroke and Underlying AF Trial).Am J Cardiol. 2015 Sep 15;116(6):889-93. doi: 10.1016/j.amjcard.2015.06.012. Epub 2015 Jun 24. Am J Cardiol. 2015. PMID: 26183793 Clinical Trial.
-
Detection of Atrial Fibrillation after Ischemic Stroke with an Insertable Cardiac Monitor: A Systematic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials.Cerebrovasc Dis. 2024;53(3):316-326. doi: 10.1159/000533265. Epub 2023 Jul 29. Cerebrovasc Dis. 2024. PMID: 37517392
Cited by
-
Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study.Stroke. 2015 Jun;46(6):1488-93. doi: 10.1161/STROKEAHA.115.008711. Epub 2015 Apr 23. Stroke. 2015. PMID: 25908460 Free PMC article. Clinical Trial.
-
Atrial fibrillation burden: a new outcome predictor and therapeutic target.Eur Heart J. 2024 Aug 16;45(31):2824-2838. doi: 10.1093/eurheartj/ehae373. Eur Heart J. 2024. PMID: 38953776 Free PMC article. Review.
-
Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.Int J Cardiol Heart Vasc. 2022 Oct 10;43:101132. doi: 10.1016/j.ijcha.2022.101132. eCollection 2022 Dec. Int J Cardiol Heart Vasc. 2022. PMID: 36246770 Free PMC article. Review.
-
Cardiac Blood-Based Biomarkers of Myocardial Stress as Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source/Cryptogenic Stroke: A Systematic Review and Meta-Analysis.J Clin Neurol. 2024 May;20(3):256-264. doi: 10.3988/jcn.2023.0068. Epub 2024 Jan 1. J Clin Neurol. 2024. PMID: 38171502 Free PMC article.
-
Rhythm monitoring strategies for atrial fibrillation detection in patients with cryptogenic stroke: A systematic review and meta-analysis.Int J Cardiol Heart Vasc. 2021 Apr 16;34:100780. doi: 10.1016/j.ijcha.2021.100780. eCollection 2021 Jun. Int J Cardiol Heart Vasc. 2021. PMID: 33948484 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical